Trump’s Chips War Has Left Intel’s New CEO With a Near-Impossible Task. Here’s Why and 5 Other Things to Know Today.
Cooler February inflation doesn’t mean Fed will lower rates, promising obesity drug could challenge Novo Nordisk and Eli ...
New Scientist6d
Ozempic is increasingly being linked to vision loss. What’s the truth?
Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...
Why This Long-Time Skeptic Finally Upgraded Novo Nordisk (NVO) to Buy
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
US FDA to Hold off Action on Weight-Loss Drug Copies Pending Court Ruling
In its Monday update, the FDA clarified that state-licensed compounding pharmacies and outsourcing facilities — which make ...
PatchMD Introduces New GLP-1 Support Patches for Individuals on Weight Loss Medications
PatchMD, a leading innovator in transdermal nutrient delivery, is excited to announce the launch of its new GLP-1 Support ...
Hims & Hers to Shut Down Dermatology Business Apostrophe
(Reuters) -Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the ...
Business Insider6d
Hims & Hers bought a skincare startup for $190 million 4 years ago. Today it shut it down.
the active ingredient in Ozempic and Wegovy, two blockbuster drugs used for weight loss. Hims & Hers has bet big on prescribing compounded versions of these drugs, including by buying its own ...
Daily Mail4d
Fat jab warning for midlife women: As experts sound alarm over sudden weight loss, dieticians reveal the foods you SHOULD be eating, and the ones you must always avoid
Recent figures suggest that more than half a million people are taking either Mounjaro or Wegovy (the version of Ozempic approved for weight loss rather than diabetes control). But the decision to ...
Dr Jack Mosley on 'gamechanger' weight loss method to beat 'food noise'
Dr Jack and his mother Dr Clare Bailey Mosley are publishing new books as they continue Dr Michael Mosley's work ...
pharmaphorum2d
Wegovy sales double, as starting restrictions start to lift
Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...